Director, Division of Coronary and Peripheral Intervention Devices
FDA
Silver Spring, Maryland, United States
Brian Pullin is the Director of the Division of Coronary & Peripheral Intervention Devices in the Office of Cardiovascular Devices at FDA. Brian joined FDA in 2010 and worked as a premarket reviewer of surgical, rehabilitation and neurological devices and then as Branch Chief of the Vascular Surgery Devices Branch. He has experience in all areas of device regulation, including Investigational Device Exemptions (IDEs), Premarket Notifications (510(k)s), Premarket Approvals (PMAs), and device reclassification. As Director of the Division of Coronary & Peripheral Intervention Devices, Brian oversees the review of a variety of interventional devices including drug coated balloons, coronary and peripheral stents, embolization devices, hypertenstion devices, and IVC filters. Brian earned his B.S.E. Degree from Duke University and his M.S. from Northwestern, both in Biomedical Engineering.